Trade Debtors Changement Date
Acadia Pharmaceuticals USD 102.35M 7.82M 2023-12
Agios Pharmaceuticals USD 2.81M 1.63M 2023-12
Alnylam Pharmaceuticals USD 327.79M 2.34M 2023-12
Amarin USD 122.4M 330K 2023-09
Amgen USD 7.27B 1.12B 2023-12
Baxter International USD 2.74B 190M 2023-12
Cara Therapeutics USD 5.73M 5.51M 2023-09
Cytokinetics USD 1.28M 1.22M 2023-12
Eli Lilly USD 10.36B 1.19B 2023-09
Esperion Therapeutics USD 42.62M 1.82M 2023-09
Halozyme Therapeutics USD 234.21M 16.88M 2023-12
Intra Cellular Therapies USD 114.02M 11.35M 2023-12
Intrexon USD 13.12M 1.29M 2023-09
Ionis Pharmaceuticals USD 97.78M 44.58M 2023-12
MannKind USD 14.9M 6.92M 2023-12
Nektar Therapeutics USD 2.2M 869K 2023-09
Peregrine Pharmaceuticals USD 24.23M 6.44M 2023-09
Pfizer USD 15B 1.58B 2023-09
Rigel Pharmaceuticals USD 23.55M 2.73M 2023-09
United Therapeutics USD 278.9M 20.3M 2023-12
Vanda Pharmaceuticals USD 33.62M 9.11M 2023-06



Halozyme Therapeutics Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.